Literature DB >> 8215572

Tuberculin response in preterm infants after BCG vaccination at birth.

M R Sedaghatian1, K Kardouni.   

Abstract

A total of 101 preterm infants between 26 and 37 weeks' gestation who received BCG vaccination at birth were evaluated between two and four months after vaccination. Altogether 32% of these infants had no visible BCG scar. All infants were then tested with tuberculin purified protein derivative (PPD) but only 70 returned for the test to be read 48-72 hours later. The test was negative in 22 (31%) and there was an induration of < or = 5 mm in another 26 (37%) of the infants. Of 22 infants with no BCG scar, 19 (86%) had an induration of < or = 5 mm. In infants with a positive BCG scar a significantly higher number had an induration of PPD > 5 mm. There were no significant differences between the rate of scarring and tuberculin conversion in the infants born before or after 32 weeks' gestation. It is considered that routine BCG vaccination at birth on preterm infants is not indicated until a much larger study has been performed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215572      PMCID: PMC1029499          DOI: 10.1136/adc.69.3_spec_no.309

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Evaluation of BCG at birth in the United Arab Emirates.

Authors:  M R Sedaghatian; I A Shana'a
Journal:  Tubercle       Date:  1990-09

2.  BCG vaccination against tuberculosis in Chicago. A twenty-year study statistically analyzed.

Authors:  S R ROSENTHAL; M L GRAHAM; D LIVERIGHT; G THORNE; V JOHNSON
Journal:  Pediatrics       Date:  1961-10       Impact factor: 7.124

3.  The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok.

Authors:  S Padungchan; S Konjanart; S Kasiratta; S Daramas; H G ten Dam
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

4.  Clinical assessment of gestational age in the newborn infant.

Authors:  L M Dubowitz; V Dubowitz; C Goldberg
Journal:  J Pediatr       Date:  1970-07       Impact factor: 4.406

5.  Tuberculin response two years after BCG vaccination at birth.

Authors:  H Grindulis; M I Baynham; P H Scott; R A Thompson; B A Wharton
Journal:  Arch Dis Child       Date:  1984-07       Impact factor: 3.791

6.  Tuberculin conversion following BCG vaccination in preterm infants.

Authors:  A H Dawodu
Journal:  Acta Paediatr Scand       Date:  1985-07

7.  Incidence of childhood tuberculosis after neonatal BCG vaccination.

Authors:  H M Curtis; I Leck; F N Bamford
Journal:  Lancet       Date:  1984-01-21       Impact factor: 79.321

8.  Tuberculin response of Sri Lankan children after BCG vaccination at birth.

Authors:  S Karalliedde; L P Katugaha; C G Uragoda
Journal:  Tubercle       Date:  1987-03
  8 in total
  7 in total

1.  Safety and effectiveness of BCG vaccination in preterm babies.

Authors:  S Thayyil-Sudhan; A Kumar; M Singh; V K Paul; A K Deorari
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-07       Impact factor: 5.747

Review 2.  Immunisation of premature infants.

Authors:  J Bonhoeffer; C-A Siegrist; P T Heath
Journal:  Arch Dis Child       Date:  2006-11       Impact factor: 3.791

3.  Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.

Authors:  Megha Saroha; M M A Faridi; Prerna Batra; Iqbal Kaur; D K Dewan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Immunogenicity of hepatitis B vaccine in preterm infants.

Authors:  O Blondheim; D Bader; M Abend; M Peniakov; D Reich; I Potesman; R Handsher; I Gidoni; N Linder
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

5.  Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring.

Authors:  Janine Jason; Lennox K Archibald; Okey C Nwanyanwu; Peter N Kazembe; Julie A Chatt; Elizabeth Norton; Hamish Dobbie; William R Jarvis
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 6.  Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability.

Authors:  Carl T D'Angio
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

7.  Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.

Authors:  Shiraz Badurdeen; Andrew Marshall; Hazel Daish; Mark Hatherill; James A Berkley
Journal:  JAMA Pediatr       Date:  2019-01-01       Impact factor: 16.193

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.